News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
800,738 Results
Type
Article (37099)
Company Profile (218)
Press Release (763420)
Multimedia
Podcasts (19)
Webinars (11)
Section
Business (224749)
Career Advice (3384)
Deals (37175)
Drug Delivery (36)
Drug Development (83274)
Employer Resources (57)
FDA (16728)
Job Trends (15501)
News (376440)
Policy (34079)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2861)
Academic (1)
Accelerated approval (23)
Adcomms (16)
Allergies (110)
Alliances (54682)
ALS (112)
Alzheimer's disease (1402)
Antibody-drug conjugate (ADC) (145)
Approvals (16962)
Artificial intelligence (272)
Autoimmune disease (93)
Automation (18)
Bankruptcy (328)
Best Places to Work (11913)
BIOSECURE Act (10)
Biosimilars (94)
Biotechnology (74)
Bladder cancer (110)
Brain cancer (43)
Breast cancer (426)
Cancer (3180)
Cardiovascular disease (238)
Career advice (2881)
Career pathing (10)
CAR-T (183)
CDC (24)
Cell therapy (466)
Cervical cancer (16)
Clinical research (70044)
Collaboration (963)
Company closure (3)
Compensation (272)
Complete response letters (31)
COVID-19 (2047)
CRISPR (49)
C-suite (672)
Cystic fibrosis (118)
Data (4645)
Decentralized trials (1)
Denatured (8)
Depression (86)
Diabetes (306)
Diagnostics (6606)
Digital health (26)
Diversity (7)
Diversity, equity & inclusion (19)
Drug discovery (139)
Drug pricing (73)
Drug shortages (8)
Duchenne muscular dystrophy (139)
Earnings (97343)
Editorial (29)
Employer branding (4)
Employer resources (53)
Events (128514)
Executive appointments (780)
FDA (18835)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (854)
Gene editing (118)
Generative AI (17)
Gene therapy (331)
GLP-1 (467)
Government (4006)
Grass and pollen (3)
Guidances (337)
Healthcare (20043)
HIV (34)
Huntington's disease (21)
IgA nephropathy (55)
Immunology and inflammation (117)
Immuno-oncology (34)
Indications (72)
Infectious disease (2204)
Inflammatory bowel disease (143)
Inflation Reduction Act (3)
Influenza (83)
Intellectual property (196)
Interviews (656)
IPO (17178)
IRA (17)
Job creations (3858)
Job search strategy (2345)
JPM (15)
Kidney cancer (14)
Labor market (40)
Layoffs (160)
Leadership (19)
Legal (8631)
Liver cancer (66)
Longevity (9)
Lung cancer (400)
Lymphoma (252)
Machine learning (29)
Management (21)
Manufacturing (387)
MASH (127)
Medical device (14237)
Medtech (14270)
Mergers & acquisitions (20670)
Metabolic disorders (725)
Multiple sclerosis (103)
NASH (9)
Neurodegenerative disease (193)
Neuropsychiatric disorders (52)
Neuroscience (2159)
Neurotech (1)
NextGen: Class of 2026 (6776)
Non-profit (4985)
Now hiring (10)
Obesity (267)
Opinion (94)
Ovarian cancer (118)
Pain (126)
Pancreatic cancer (187)
Parkinson's disease (175)
Partnered (20)
Patents (387)
Patient recruitment (336)
Peanut (47)
People (63933)
Pharmaceutical (28)
Pharmacy benefit managers (11)
Phase 1 (21761)
Phase 2 (30560)
Phase 3 (21866)
Pipeline (3915)
Policy (127)
Postmarket research (3122)
Preclinical (9732)
Press Release (72)
Prostate cancer (155)
Psychedelics (27)
Radiopharmaceuticals (252)
Rare diseases (537)
Real estate (6676)
Recruiting (26)
Regulatory (24220)
Reports (14)
Research institute (2451)
Resumes & cover letters (533)
Rett syndrome (25)
RNA editing (7)
RSV (28)
Schizophrenia (99)
Series A (118)
Series B (79)
Service/supplier (7)
Sickle cell disease (60)
Special edition (3)
Spinal muscular atrophy (119)
Sponsored (13)
Startups (3623)
State (1)
Stomach cancer (6)
Supply chain (46)
Tariffs (33)
The Weekly (11)
Vaccines (548)
Venture capital (33)
Weight loss (157)
Women's health (51)
Worklife (2)
Date
Last 7 days (388)
Last 30 days (1224)
Last 365 days (19682)
2026 (2113)
2025 (19924)
2024 (30144)
2023 (41457)
2022 (52033)
2021 (56851)
2020 (55823)
2019 (48502)
2018 (36752)
2017 (33513)
2016 (34887)
2015 (41550)
2014 (37454)
2013 (34647)
2012 (36689)
2011 (36637)
2010 (37640)
Location
Africa (812)
Alabama (76)
Alaska (7)
Arizona (272)
Arkansas (9)
Asia (46367)
Australia (7945)
California (7671)
Canada (2427)
China (562)
Colorado (375)
Connecticut (373)
Delaware (204)
Europe (106373)
Florida (1240)
Georgia (248)
Hawaii (2)
Idaho (65)
Illinois (625)
India (32)
Indiana (385)
Iowa (15)
Japan (274)
Kansas (126)
Kentucky (14)
Louisiana (18)
Maine (78)
Maryland (1032)
Massachusetts (5296)
Michigan (271)
Minnesota (463)
Mississippi (4)
Missouri (90)
Montana (33)
Nebraska (27)
Nevada (104)
New Hampshire (55)
New Jersey (2050)
New Mexico (26)
New York (2194)
North Carolina (1133)
North Dakota (8)
Northern California (3827)
Ohio (227)
Oklahoma (12)
Oregon (32)
Pennsylvania (1668)
Puerto Rico (21)
Rhode Island (27)
South America (1271)
South Carolina (54)
Southern California (3007)
Tennessee (103)
Texas (1258)
United States (28135)
Utah (216)
Virginia (156)
Washington D.C. (52)
Washington State (692)
West Virginia (2)
Wisconsin (36)
Wyoming (2)
800,738 Results for "oxford university press".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer
January 6, 2026
·
6 min read
Press Releases
The Oxford-Harrington Rare Disease Centre Advances Discovery of Therapies for Friedreich’s Ataxia (FA)
February 9, 2026
·
7 min read
Press Releases
Oxford-Harrington Rare Disease Centre Invites Proposals for 2026 Award
January 16, 2026
·
2 min read
Press Releases
Press Release: Sanofi completes the acquisition of Dynavax
February 10, 2026
·
6 min read
Press Releases
Oxford Nanopore Receives Regulatory Approval for its First Diagnostic Device in the UK and Europe
January 12, 2026
·
2 min read
Press Releases
Press Release: Myqorzo and Redemplo approved in China
January 16, 2026
·
8 min read
Press Releases
Press Release: Belén Garijo to become Chief Executive Officer of Sanofi
February 12, 2026
·
6 min read
Press Releases
Press Release: Sanofi’s amlitelimab confirms its potential in atopic dermatitis
January 26, 2026
·
14 min read
Press Releases
Oxford-Harrington Rare Disease Centre Announces 2025 Scholars Advancing Promising Treatments
November 21, 2025
·
4 min read
Press Releases
Press Release: Sanofi announces the signing of a share buyback mandate for up to €1 billion
February 3, 2026
·
4 min read
1 of 80,074
Next
